CompletedNCT02197364

The Role of KL-6 in the Clinical Diagnosis of ILD

Studying Interstitial lung disease

Last synced from ClinicalTrials.gov

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Shanghai Pulmonary Hospital, Shanghai, China
Principal Investigator
Li Hui Ping
Shanghai Pulmonary Hospital , Tongji University
Enrollment
1190 enrolled
Eligibility
14-90 years · All sexes
Timeline
20132014

Collaborators

Fujirebio Diagnostics, Inc.

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT02197364 on ClinicalTrials.gov

Other trials for Interstitial lung disease

Additional recruiting or active studies for the same condition.

See all trials for Interstitial lung disease

← Back to all trials